Why is TPST stock up today?
In plain English
The only news (“Tempest to Advance Dual-Targeting CAR-T Platform with Clin…”) is stale (140d old) — too old to explain today's move. Likely momentum, not news.
What it means for you
Choppy and directionless — no clear pattern in either direction. Risk level: elevated.
About Tempest Therapeutics, Inc. Common Stock
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate,
See it in context
TPST opened +41.6% versus the prior close, then finished +13.1% from its open, on 104.6M shares traded.
Against the whole market that day, 33.5% of US stocks closed higher (median move -0.2%) — so TPST rose even as most stocks fell. See the full market recap →
More movers: today's biggest gainers · today's biggest gap-ups · all screeners · why other stocks are moving
Learn the basics: how to read a chart · what volume means · grade TPST’s chart with the AI reader →